|Bid||3.5100 x 900|
|Ask||4.2100 x 900|
|Day's Range||3.7500 - 4.0200|
|52 Week Range||2.5000 - 16.5000|
|Beta (5Y Monthly)||-0.91|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb. 11, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||14.00|
Nemaura Medical, Inc. (NASDAQ: NMRD)("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces it has appointed Justin Mclarney as Chief Finance Officer, effective September 15, 2020.
Nemaura Medical, Inc. (NASDAQ: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT®, its non-invasive and flexible continuous glucose monitor ("CGM"), together with BEAT™diabetes, a planned health subscription service designed to help people with Type 2 diabetes and prediabetes through personalized lifestyle coaching, today announced that its CEO Dr. Faz Chowdhury will be presenting at the LD 500 investor conference on Thursday, September 3, 2020 at 10:20 a.m. ET.
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.